Clinical Trial Update: Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India

View source ↗

Summary

A completed AstraZeneca-sponsored clinical trial update evaluating the management of dyslipidemia in adults with type 2 diabetes mellitus in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia, Type 2 Diabetes Mellitus | Status: COMPLETED